Themes
Business
Talent
At the park
Communities
Jobs & internships
Events
News
Contact
Leiden researchers edge closer to potential cure for type 1 diabetes
Researchers at the Leiden University Medical Center (LUMC) have announced promising early results from a clinical trial using lab-grown insulin-producing islet cells derived from human stem cells. In this phase 1โ2 study involving a small group of patients with severe...
VarmX Secures IND Approval for Phase 3 Trial of VMX-C001 in Emergency Surgery
VarmX, a biotechnology firm specializing in solutions for anticoagulation reversal, has obtained Investigational New Drug (IND) approval to advance its lead candidate, VMXโC001, into a pivotal Phase 3 clinical trial. The study will investigate the effectiveness of a...
Key Region Leiden launch
๐๐ผ๐ ๐ฑ๐ผ ๐๐ฒ ๐๐๐ฟ๐ป ๐๐ฐ๐ถ๐ฒ๐ป๐๐ถ๐ณ๐ถ๐ฐ ๐ธ๐ป๐ผ๐๐น๐ฒ๐ฑ๐ด๐ฒ ๐ถ๐ป๐๐ผ ๐ฟ๐ฒ๐ฎ๐น ๐๐ผ๐น๐๐๐ถ๐ผ๐ป๐, ๐ณ๐ฎ๐๐๐ฒ๐ฟ, ๐๐บ๐ฎ๐ฟ๐๐ฒ๐ฟ, ๐ฎ๐ป๐ฑ ๐๐ผ๐ด๐ฒ๐๐ต๐ฒ๐ฟ? Thatโs the question Key Region Leiden is working to answer. Launched on July 7 at Leiden Bio Science Park, this new regional partnership brings together seven municipalities, three...
Progress Acquires Methnani & Associates to Expand Microbiology Expertise
Founded by Fathia Methnani nearly two decades ago, the consultancy built a strong reputation advising pharma and biotech companies on aseptic processes, cleanroom behaviour, and microbial risk mitigation. Fathia will remain involved...